Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bone turnover markers as predictors of treatment break outcome
2016-003110-27Phase 4Completed
- Sponsor
- Aarhus University
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of alendronate in osteoporosis (2 arms), sponsored by Aarhus University. Primary endpoint: Bone loss 12 months after stopping alendronate. Started Jul 2016; status: completed.
02
Drugs
alendronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on 2016-003110-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003110-27.